Immediate Impact

1 from Science/Nature 64 standout
Sub-graph 1 of 23

Citing Papers

A covalent peptide-based lysosome-targeting protein degradation platform for cancer immunotherapy
2025 Standout
Tissue macrophages: origin, heterogenity, biological functions, diseases and therapeutic targets
2025 Standout
2 intermediate papers

Works of Chunyang Ma being referenced

Liposomal clodronate combined with Cisplatin or Sorafenib inhibits hepatocellular carcinoma cell proliferation, migration and invasion by suppressing FOXQ1 expression
2020
Transferrin and cell-penetrating peptide dual-functioned liposome for targeted drug delivery to glioma.
2015

Author Peers

Author Last Decade Papers Cites
Chunyang Ma 37 175 64 64 22 330
Zhiyong Wang 26 202 72 38 17 370
Shuang Fei 34 179 35 32 24 338
Wei Liu 9 237 110 44 20 326
Hongming Ji 27 135 64 11 28 304
Hongjuan Li 12 138 37 21 23 352
Jiaxin Zhang 9 145 42 19 27 347
Wentao Shi 61 146 56 20 33 366
Dennis A. Laska 50 89 57 16 16 365
Tushuai Li 46 142 43 23 23 290
Jie Xue 15 97 25 23 19 356

All Works

Loading papers...

Rankless by CCL
2026